Ascentage Pharma Group International revenue was $95.69M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2026) ending on Jun 30, 2026 was N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, AAPG annual revenue was $82.1M, with -38.9% growth year-over-year.
AAPG past revenue growth
How has AAPG's revenue growth performed historically?
On Aug 19, 2026, Ascentage Pharma Group International (NASDAQ: AAPG) reported Q2 2026 revenue of N/A up N/A year over year. In the same quarter last year, Ascentage Pharma Group International's revenue was N/A.
What was Ascentage Pharma Group International's revenue in 2025?
Ascentage Pharma Group International's annual revenue for the twelve months ending Dec 31, 2025 was $82.06 million, a 38.93% decrease year over year.
How much does Ascentage Pharma Group International make in a day?
Based on Ascentage Pharma Group International annual revenue for the past three years, AAPG makes an average of $226,183.58 per day.
What was Ascentage Pharma Group International's annual revenue growth in the past year?
As of Q3 2026, Ascentage Pharma Group International's revenue has grown 73.48% year over year. This is 181.22 percentage points lower than the US Biotechnology industry revenue growth rate of 254.71%. Ascentage Pharma Group International's revenue in the past year totaled $95.69 million.
How much does Ascentage Pharma Group International make in a year?
Ascentage Pharma Group International's revenue by year for the past three years is:
Ascentage Pharma Group International's revenue for the twelve months ending Dec 31, 2025 was $82.06 million, a 38.93% decrease year over year.
Ascentage Pharma Group International's annual revenue for Dec 31, 2024 was $134.37 million, a 330.2% increase from 2023.
Ascentage Pharma Group International's annual revenue for 2023 was $31.23 million, a 3.71% increase from 2022.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.